Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes [PDF]
Bailey, Clare +6 more
core +1 more source
The clinical effects and mechanism of action of ranibizumab in treating myopic choroidal neovascularization. [PDF]
Gu W, Wang Z, Peng D, Gu Y.
europepmc +1 more source
Discerning Between Macular Hemorrhages Due to Macular Neovascularization or Due to Spontaneous Bruch’s Membrane Rupture in High Myopia: A Comparative Analysis Between OCTA and Fluorescein Angiography [PDF]
Borrelli, E.
core +1 more source
Systemic Oxidative Stress Level as a Pathological and Prognostic Factor in Myopic Choroidal Neovascularization. [PDF]
Wang J +5 more
europepmc +1 more source
Baseline characteristics of myopic choroidal neovascularization in patients above 50 years old and prognostic factors after intravitreal conbercept treatment. [PDF]
Wang HY +7 more
europepmc +1 more source
One-Year Outcome of Intravitreal Injection of Ranibizumab Biosimilar for Myopic Choroidal Neovascularization in Japanese Patients. [PDF]
Tomita M +7 more
europepmc +1 more source
Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real-world setting in China : Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization. [PDF]
Nie X, Wang Y, Yi H, Qiao Y.
europepmc +1 more source
Treatment of myopic choroidal neovascularization: a network meta-analysis and review. [PDF]
Glachs L +7 more
europepmc +1 more source

